Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X In

Journal Article · · J. Med. Chem.

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
DOE - Office Of Science; INDUSTRY
OSTI ID:
1901314
Journal Information:
J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (20) Vol. 65
Country of Publication:
United States
Language:
ENGLISH

References (62)

P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action journal February 2012
A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria journal February 2021
Synthesis of amino heterocycle aspartyl protease inhibitors journal January 2016
Species Differences in Distribution and Prediction of Human Vss from Preclinical Data journal August 2011
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS  -amyloid in animal models and in Alzheimers disease patients journal November 2016
Retinal Toxicity Induced by a Novel β-secretase Inhibitor in the Sprague-Dawley Rat journal October 2014
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials journal August 2021
Features and development of Coot journal March 2010
The cellular and molecular basis for malaria parasite invasion of the human red blood cell journal September 2012
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria journal July 2015
An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS journal August 2011
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation journal December 2009
Quantitative measurement of Plasmodium -infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence journal March 2009
A dual target of Plasmepsin IX and X: Unveiling the atomistic superiority of a core chemical scaffold in malaria therapy journal November 2018
Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity journal July 2020
Subtle Changes in Endochin-Like Quinolone Structure Alter the Site of Inhibition within the Cytochrome bc 1 Complex of Plasmodium falciparum journal January 2015
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models journal March 2007
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic journal August 2017
Thousands of chemical starting points for antimalarial lead identification journal May 2010
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment journal May 2018
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management journal July 2020
Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness journal July 2021
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax journal July 2022
Structural Insights Into Key Plasmodium Proteases as Therapeutic Drug Targets journal March 2019
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine journal August 2018
Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria journal September 2020
Long-term live imaging reveals cytosolic immune responses of host hepatocytes againstPlasmodiuminfection and parasite escape mechanisms journal September 2015
A multifunctional serine protease primes the malaria parasite for red blood cell invasion journal February 2009
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling journal November 2012
Egress and invasion machinery of malaria: an in-depth look into the structural and functional features of the flap dynamics of plasmepsin IX and X journal January 2018
Transport mechanisms at the malaria parasite-host cell interface journal April 2021
Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations journal December 2011
Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme journal February 2022
PHENIX : building new software for automated crystallographic structure determination journal October 2002
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle journal April 2020
Malaria parasite plasmepsins: More than just plain old degradative pepsins journal June 2020
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase journal April 2017
Rate- and Extent-Limiting Factors of Oral Drug Absorption: Theory and Applications journal September 2015
β‐Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment journal August 2012
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery journal December 2011
New developments in anti-malarial target candidate and product profiles journal January 2017
Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors journal October 2016
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present) journal January 2020
Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond journal May 2012
A novel multiple-stage antimalarial agent that inhibits protein synthesis journal June 2015
Evaluation of Aminohydantoins as a Novel Class of Antimalarial Agents journal December 2013
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials journal August 2019
The Corrected Traditional Equations for Calculation of Hepatic Clearance that Account for the Difference in Drug Ionization in Extracellular and Intracellular Tissue Water and the Corresponding Corrected PBPK Equation journal March 2011
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids journal May 2007
A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress journal October 2017
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes journal May 2008
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease journal January 2014
Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion journal October 2017
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay journal January 2019
Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases journal March 2018
Proteases in Malaria Parasites - A Phylogenomic Perspective journal September 2011
A framework for assessing the risk of resistance for anti-malarials in development journal August 2012
Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set journal August 2016
Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2R null Mice Engrafted with Human Erythrocytes journal July 2009
Pushing the boundaries of molecular replacement with maximum likelihood journal September 2001
Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome journal April 2020
A druggable secretory protein maturase of Toxoplasma essential for invasion and egress journal September 2017

Similar Records

Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Ac
Journal Article · 2021 · J. Med. Chem. · OSTI ID:1829890

Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors
Journal Article · 2016 · ACS Medicinal Chemistry Letters · OSTI ID:1404955

Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious
Journal Article · 2021 · Bioorg. Med. Chem. Lett. · OSTI ID:1832564

Related Subjects